Skip to main content
logo
StemCell Institute Inc. (TYO:7096)
Japan flag Japan · Delayed Price · Currency is JPY
748.00
-1.00 (-0.13%)
Sep 16, 2026, 3:30 PM JST

StemCell Institute Financials Overview

Millions JPY. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
2,8112,8112,6792,4812,0911,781
Revenue Growth
4.93%4.93%7.98%18.65%17.41%26.40%
Gross Profit
1,7121,7121,6921,5761,3361,111
Operating Income
203203419414298227
Net Income
155155385310198133
Earnings Per Share
15.3515.3537.5930.2519.3226.26
EPS Growth
-59.17%-59.17%24.25%56.57%-26.42%106.16%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
2,8342,8343,2002,8453,3243,511
Total Debt
47247251785-
Net Cash (Debt)
2,3622,3622,6832,8373,3193,511
Net Cash Growth
-11.96%-11.96%-5.43%-14.52%-5.47%28.00%
Net Cash Per Share
233.89233.89261.97276.87323.91693.28

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
737346733499469
Capital Expenditures
-409-409-478-183-56-181
Free Cash Flow
-336-336-1115143288
Free Cash Flow Growth
---251.16%-85.07%-

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
60.90%60.90%63.16%63.52%63.89%62.38%
Operating Margin
7.22%7.22%15.64%16.69%14.25%12.75%
Pretax Margin
7.72%7.72%21.05%17.73%13.30%11.85%
Profit Margin
5.51%5.51%14.37%12.50%9.47%7.47%
FCF Margin
-11.95%-11.95%-0.41%6.09%2.06%16.17%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
48.8049.7736.1265.45130.15154.66
Forward PE
52.1039.49----
P/FCF Ratio
---134.36599.3071.42
PS Ratio
2.682.745.198.1812.3211.55